| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 1041 |
| 1 | PREDNISONE | 365 |
| 2 | ABATACEPT | 322 |
| 3 | INFLIXIMAB | 322 |
| 4 | ADALIMUMAB-AATY | 255 |
| 5 | ADALIMUMAB | 254 |
| 6 | ADALIMUMAB-ADAZ | 217 |
| 7 | ADALIMUMAB-FKJP | 202 |
| 8 | MESALAMINE | 202 |
| 9 | METHOTREXATE SODIUM | 143 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-STBA | 8 | 0.0216 |
| 1 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 69 | 0.0194 |
| 2 | ADALIMUMAB-RYVK | 21 | 0.0193 |
| 3 | ETRANACOGENE DEZAPARVOVEC | 1 | 0.0154 |
| 4 | ADALIMUMAB-AACF | 5 | 0.0149 |
| 5 | FERRIC SULFATE | 1 | 0.0125 |
| 6 | VEDOLIZUMAB | 1041 | 0.0120 |
| 7 | USTEKINUMAB-AUUB | 2 | 0.0114 |
| 8 | INFLIXIMAB-DYYB | 34 | 0.0099 |
| 9 | ARGININE HYDROCHLORIDE | 1 | 0.0097 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 1041 |
| 1 | Corticosteroid [EPC] | 536 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 498 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 322 |
| 4 | Aminosalicylate [EPC] | 215 |
| 5 | Interleukin-23 Antagonist [EPC] | 137 |
| 6 | Interleukin-12 Antagonist [EPC] | 135 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 130 |
| 8 | Purine Antimetabolite [EPC] | 126 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 105 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 1041 | 0.0120 |
| 1 | Interferon gamma Blocker [EPC] | 2 | 0.0084 |
| 2 | Tyrosine Kinase 2 Inhibitor [EPC] | 12 | 0.0040 |
| 3 | Neurokinin 3 Receptor Antagonist [EPC] | 8 | 0.0035 |
| 4 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 5 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 10 | 0.0026 |
| 6 | Uric Acid-specific Enzyme [EPC] | 10 | 0.0026 |
| 7 | Cholinergic Muscarinic Agonist [EPC] | 7 | 0.0025 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 322 | 0.0023 |
| 9 | Aminosalicylate [EPC] | 215 | 0.0021 |